Your Account
Filter Articles
Sort
Categories
- #EMSPVirtual2021
- Annual Report
- Associate members
- Document
- EMSP Events
- EMSP Events|EMSP News
- EMSP News
- EMSP News|From Europe
- EMSP News|From Europe|Stakeholder Events
- EMSP News|MS Research
- EMSP News|Press Releases
- EMSP News|Young People with MS
- From Europe
- From Europe|Member News
- From Europe|Stakeholder Events
- From Europe|Young People with MS
- Full members
- Full members|Member News
- Member News
- Member News|Young People with MS
- MS Research
- News – EMSP
- News2
- Press Releases
- Project Updates
- Stakeholder Events
- Uncategorized
- Young People with MS
Nose-to-Brain-Patch Final Outcomes
29.09.2021
Effective drugs for the treatment of diseases of the central nervous system such as multiple sclerosis do exist. However, the…
Portuguese Project Offers Alternative therapy for Multiple Sclerosis Treatment
29.09.2021
EM’ Equilíbrio (‘MS Balance’ in English) is a project developed by the Portuguese MS Society (SPEM), co-financed by the Portuguese…
Updated global COVID-19 advice for people with MS
06.06.2021
Global COVID-19 advice for people with MS | Last updated: 23 March 2022 What’s on this page? Global COVID-19 advice…
Tracking the causes of multiple sclerosis by comparing the immune systems of twins
31.03.2021
The Swiss MS Society provided us with its interim report upon their recent research initiative run by the Institute of…
#EMSPVirtual2020 Summary
31.03.2021
Mid-November was not the usual time for an EMSP conference. In the last weeks of 2020, the European MS community…
Childhood MS on Rare Diseases Day 2021
26.02.2021
Do you remember when you were 9? Or 15? We might not recall all our youth but there are parts…
